A similar induction of genes involved in oxidative phosphorylation, associated with increased mitochondrial mass, was seen in mice treated with the PGC-1α activator resveratrol, which protects mice from developing obesity and insulin resistance [49]. Here, PPARGC1A is linked to obesity due to melanocortin 4 receptor deficiency.